Purchase Order 75N91023P00714
Award Date 8/7/23
Potential Completion Date 8/31/23
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Irvine, CA 92618, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $93,969.03 firm fixed price delivery order contract to Illumina, Inc. for reagents and consumables. The place of performance will be Illumina's facilities located in San Diego, California. The period of performance is from December 20, 2023 through January 19, 2024. This delivery order was awarded under an existing government-wide acquisition contract vehicle or blanket...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $146,062.52 firm fixed price delivery order to Illumina, Inc. for reagents and consumables. The place of performance is San Diego, California. The period of performance is from August 15, 2023 through September 14, 2023. No set aside designation or subcontractors were identified. The award will provide reagents and consumables to support the NCI's biomedical research...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $60,305.60 firm fixed price delivery order to Illumina, Inc. for reagents and consumables. The place of performance will be Illumina's facilities located in San Diego, California. The period of performance is one month, from July 31, 2023 through August 30, 2023. No set aside designation or subcontractors were identified. This delivery order is likely in support of the...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $16,000 purchase order to Invivoscribe, Inc. for biological reagents. Invivoscribe will provide the reagents to the National Cancer Institute under a firm fixed price contract executed on December 15, 2023 and concluding on January 31, 2024. The contract will be performed in San Diego, California by Invivoscribe, which specializes in reagents, kits, and services for clinical molecular...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded Roche Diagnostics Corporation a $20,463.87 firm fixed price delivery order for reagents and consumables. The contract has no set-aside designation and runs through January 13, 2023. As the largest biomedical research agency in the world, the National Cancer Institute works with both public and private partners to better understand, diagnose, and treat cancer. This delivery order...
- The National Institutes of Health's National Cancer Institute awarded a $23,086 delivery order to Illumina, Inc. under an unspecified government-wide acquisition contract for biological reagents. The one-month contract will provide BIOLOGICAL AND REAGENTS to support the agency's cancer research efforts. Performance will take place in San Diego, California. The firm fixed price contract runs from July 11, 2023 through August 10, 2023 with no set aside designation. Illumina will serve as the prime...
- The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $120,611.20 firm fixed price delivery order contract to Illumina, Inc. of San Diego, California. The contract is for reagents and consumables to be provided between September 10, 2023 and October 9, 2023 at the prime contractor's listed place of performance in San Diego. No additional details were provided on the original solicitation or associated...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $25,731 delivery order contract to Illumina, Inc. of San Diego, California. Under the terms of the firm fixed price delivery order, Illumina will provide reagents and consumables to the NCI in support of its biomedical research efforts. The one month period of performance extends from August 13th to September 12th, 2023. No subcontractors or set aside designations were...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $20,570 purchase order to Oxford Nanopore Technologies Inc. for laboratory supplies. The firm fixed price contract runs from August 17, 2023 to January 5, 2024 and will be performed in New York, New York. As the National Cancer Institute supports research to advance cancer prevention, diagnosis, and treatment, this contract will likely provide supplies to enable NCI-funded laboratory...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $186,847 delivery order contract to Illumina, Inc. of San Diego, California. Under the terms of the firm fixed price delivery order, Illumina will provide reagents and consumables to the NCI in support of its biomedical research efforts. The one month period of performance extends from August 10th to September 9th, 2023. No subcontractors or set aside designations were...